An unresolved problem with clinical use of antiplatelet therapy is that a significant number of individuals either still get thrombosis or run the risk of life-threatening bleeding - Pat Metharom


image by: Buddy Stephens

HWN Recommends

A new anti-platelet drug shows potential for treating blood vessel clots in heart attacks, strokes and, possibly, COVID-19

Clots obstruct blood vessels and can be deadly. They cause heart attack, stroke and are also a major problem in severe cases of COVID-19 patients. Treating clots with available drugs, however, can cause blood vessel leaking and bleeding, which can also be deadly in some circumstances.

To address this problem, my colleagues and I have engineered a new anti-platelet drug designed to prevent vessel-blocking blood clots without causing bleeding. This drug shows promise in treating heart attack and may also be useful for other severe conditions caused by clots, such as stroke and COVID-19 patients with clots and blood vessel leaks.

As a scientist studying the biology of blood cells…

read full article


Related Articles

Stay Connected

©2021 | HealthWorldNet, Inc. | 114816

Last Updated : Saturday, January 30, 2021